BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24306962)

  • 1. Native American ancestry, lung function, and COPD in Costa Ricans.
    Chen W; Brehm JM; Boutaoui N; Soto-Quiros M; Avila L; Celli BR; Bruse S; Tesfaigzi Y; Celedón JC
    Chest; 2014 Apr; 145(4):704-710. PubMed ID: 24306962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Cigarette Smoking and Polygenic Risk Score on Reduced Lung Function.
    Kim W; Moll M; Qiao D; Hobbs BD; Shrine N; Sakornsakolpat P; Tobin MD; Dudbridge F; Wain LV; Ladd-Acosta C; Chatterjee N; Silverman EK; Cho MH; Beaty TH
    JAMA Netw Open; 2021 Dec; 4(12):e2139525. PubMed ID: 34913977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study.
    Parker MM; Foreman MG; Abel HJ; Mathias RA; Hetmanski JB; Crapo JD; Silverman EK; Beaty TH;
    Genet Epidemiol; 2014 Nov; 38(7):652-9. PubMed ID: 25112515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study.
    Powell R; Davidson D; Divers J; Manichaikul A; Carr JJ; Detrano R; Hoffman EA; Jiang R; Kronmal RA; Liu K; Punjabi NM; Shahar E; Watson KE; Rotter JI; Taylor KD; Rich SS; Barr RG
    Thorax; 2013 Jul; 68(7):634-642. PubMed ID: 23585509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts.
    Moll M; Sakornsakolpat P; Shrine N; Hobbs BD; DeMeo DL; John C; Guyatt AL; McGeachie MJ; Gharib SA; Obeidat M; Lahousse L; Wijnant SRA; Brusselle G; Meyers DA; Bleecker ER; Li X; Tal-Singer R; Manichaikul A; Rich SS; Won S; Kim WJ; Do AR; Washko GR; Barr RG; Psaty BM; Bartz TM; Hansel NN; Barnes K; Hokanson JE; Crapo JD; Lynch D; Bakke P; Gulsvik A; Hall IP; Wain L; ; ; Weiss ST; Silverman EK; Dudbridge F; Tobin MD; Cho MH
    Lancet Respir Med; 2020 Jul; 8(7):696-708. PubMed ID: 32649918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
    Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
    Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Serum Folate Concentration Is Associated with Better Lung Function in Male Chronic Obstructive Pulmonary Disease Patients Who Are Current Smokers: Analysis of Nationwide Population-Based Survey.
    Kim T; Oak CH; Jung MH; Jang TW; Kim J
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 11. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.
    Kubota Y; Folsom AR; Matsushita K; Couper D; Tang W
    Atherosclerosis; 2018 Jan; 268():225-230. PubMed ID: 29079449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short telomere length, lung function and chronic obstructive pulmonary disease in 46,396 individuals.
    Rode L; Bojesen SE; Weischer M; Vestbo J; Nordestgaard BG
    Thorax; 2013 May; 68(5):429-35. PubMed ID: 23268483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
    Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female reproductive history in relation to chronic obstructive pulmonary disease and lung function in UK biobank: a prospective population-based cohort study.
    Tang R; Fraser A; Magnus MC
    BMJ Open; 2019 Oct; 9(10):e030318. PubMed ID: 31662371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHRNA3 and CYP3A5*3 genotype, lung function and chronic obstructive pulmonary disease in the general population.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenet Genomics; 2014 Apr; 24(4):220-9. PubMed ID: 24535486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the causal role of physical activity and leisure sedentary behaviours with chronic obstructive pulmonary disease: a Mendelian randomisation study.
    Xiao L; Li W; Li F; Chen X; Xu Y; Hu Y; Fu Y; Feng L
    BMJ Open Respir Res; 2024 Apr; 11(1):. PubMed ID: 38688688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.
    Bhatt SP; Kim YI; Harrington KF; Hokanson JE; Lutz SM; Cho MH; DeMeo DL; Wells JM; Make BJ; Rennard SI; Washko GR; Foreman MG; Tashkin DP; Wise RA; Dransfield MT; Bailey WC;
    Thorax; 2018 May; 73(5):414-421. PubMed ID: 29326298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.
    Mohammad Y; Shaaban R; Al-Zahab BA; Khaltaev N; Bousquet J; Dubaybo B
    Int J Chron Obstruct Pulmon Dis; 2013; 8():473-82. PubMed ID: 24124359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.